Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Siva Nageswara Rao Gajula, Megha Sajakumar Pillai, Gananadhamu Samanthula & Rajesh Sonti. (2021) Cytochrome P450 Enzymes: A Review on Drug Metabolizing Enzyme Inhibition Studies in Drug Discovery and Development. Bioanalysis 13:17, pages 1355-1378.
Read now
Read now
Daniel Krewski, Daniel Acosta$suffix/text()$suffix/text(), Melvin Andersen, Henry Anderson, John
C. Bailar$suffix/text()$suffix/text(), Kim Boekelheide, Robert Brent, Gail Charnley, Vivian
G. Cheung, Sidney Green$suffix/text()$suffix/text(), Karl
T. Kelsey, Nancy
I. Kerkvliet, Abby
A. Li, Lawrence McCray, Otto Meyer, Reid
D. Patterson, William Pennie, Robert
A. Scala, Gina
M. Solomon, Martin Stephens, James Yager, Lauren Zeise & Staff of Committee on Toxicity Testing and Assessment of Environmental Agents. (2010) Toxicity Testing in the 21st Century: A Vision and a Strategy. Journal of Toxicology and Environmental Health, Part B 13:2-4, pages 51-138.
Read now
Read now
Glyn B Steventon & Stephen C Mitchell. (2009) Phenylalanine 4-monooxygenase and the role of endobiotic metabolism enzymes in xenobiotic biotransformation. Expert Opinion on Drug Metabolism & Toxicology 5:10, pages 1213-1221.
Read now
Read now
Roberto Stasi. (2009) Eltrombopag: the discovery of a second generation thrombopoietin-receptor agonist. Expert Opinion on Drug Discovery 4:1, pages 85-93.
Read now
Read now
Isabel Gomez-Orellana. (2005) Strategies to improve oral drug bioavailability. Expert Opinion on Drug Delivery 2:3, pages 419-433.
Read now
Read now
N. Hagen, A. K. Olsen, J. V. Andersen, J. Tjørnelund & S. H. Hansen. (2002) Characterization of mixtures of recombinant human cytochrome P450s as a screening model for metabolic stability in drug discovery. Xenobiotica 32:9, pages 749-759.
Read now
Read now
Articles from other publishers (81)
Kuldeep Rajpoot, Mamata Panchal, Bhakti Pawar, Nupur Vasdev, Tanisha Gupta, Muktika Tekade, Manish Sharma & Rakesh Kumar Tekade. 2024. Public Health and Toxicology Issues Drug Research, Volume 2. Public Health and Toxicology Issues Drug Research, Volume 2
407
449
.
MARK P. GRILLO. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
703
743
.
Zachary D. Kelley, Mark A. Lovell & Bert C. Lynn. (2021) Pharmacokinetic and metabolic analysis of an Alzheimer's disease therapeutic in rat serum via microfluidic CZE–MS. Biomedical Chromatography 36:1.
Crossref
Crossref
Jangampalli Adi Pradeepkiran, S.B. Sainath & K.V.L. Shrikanya. 2021. Brucella Melitensis. Brucella Melitensis
133
176
.
Maha S. Almutairi, Adnan A. Kadi, Reem I. Al-Wabli, Mohamed W. Attwa & Mohamed I. Attia. (2020) Fragmentation pattern of certain isatin–indole antiproliferative conjugates with application to identify their in vitro metabolic profiles in rat liver microsomes by liquid chromatography tandem mass spectrometry. Open Chemistry 18:1, pages 503-515.
Crossref
Crossref
Michael Davies, Rhys D.O. Jones, Ken Grime, Rasmus Jansson-Löfmark, Adrian J. Fretland, Susanne Winiwarter, Paul Morgan & Dermot F. McGinnity. (2020) Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades. Trends in Pharmacological Sciences 41:6, pages 390-408.
Crossref
Crossref
Angela King-Herbert & Mary Ann Vasbinder. 2020. The Laboratory Rat. The Laboratory Rat
849
862
.
Vijayabhaskar Veeravalli, Lakshmi Mohan Vamsi Madgula & Pratima Srivastava. 2019. Mass Spectrometry - Future Perceptions and Applications. Mass Spectrometry - Future Perceptions and Applications.
Rama K. Mishra, Kristine K. Deibler, Matthew R. Clutter, Purav P. Vagadia, Matthew O’Connor, Gary E. Schiltz, Raymond Bergan & Karl A. Scheidt. (2019) Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential Charges. Journal of Chemical Information and Modeling 59:10, pages 4460-4466.
Crossref
Crossref
Sathya Babu, Santhosh Kumar Nagarajan & Thirumurthy Madhavan. (2019) Investigation of Empirical and Semi‐Empirical Charges to Study the Effects of Partial Charges on Quality and Prediction Accuracy in 3D‐QSAR. ChemistrySelect 4:14, pages 3990-4002.
Crossref
Crossref
Xiaokang Wang, Caiyun Jiang, Xiaosong Wu, Peng Zou & Zhufeng Wu. (2018) Substrate Selectivity for UDP-glucuronosyltransferase1A8 using the Pharmacophore Approach. International Journal of Pharmacology 14:3, pages 320-328.
Crossref
Crossref
Ekramy Elmorsy, Ayat Al-Ghafari, Amal Misbah Aggour, Raheela Khan & Saad Amer. (2017) The role of oxidative stress in antipsychotics induced ovarian toxicity. Toxicology in Vitro 44, pages 190-195.
Crossref
Crossref
Masashi Kato, Hiroto Ohtake, Hideyuki Sato, Yoshiki Seto & Satomi Onoue. (2017) Enzymatic reactive oxygen species assay to evaluate phototoxic risk of metabolites. Toxicology Letters 278, pages 59-65.
Crossref
Crossref
Adnan A. Kadi, Nasser S. Al-Shakliah, Wencui Yin & A.F.M. Motiur Rahman. (2017) In vitro investigation of metabolic profiling of newly developed topoisomerase inhibitors (ethyl fluorescein hydrazones, EtFLHs) in RLMs by LC–MS/MS. Journal of Chromatography B 1054, pages 93-104.
Crossref
Crossref
A.F.M. Motiur Rahman, Nasser S. Al-Shakliah, Wencui Yin & Adnan A. Kadi. (2017) In vitro Investigation of Metabolic Profiling of a Potent Topoisomerase Inhibitors Fluorescein Hydrazones (FLHs) in RLMs by LC-MS/MS. Journal of Chromatography B 1054, pages 27-35.
Crossref
Crossref
Ekramy Elmorsy, Ayat Al-Ghafari, Amal Misbah Aggour, Soaad Mohamed Mosad, Raheela Khan & Saad Amer. (2017) Effect of antipsychotics on mitochondrial bioenergetics of rat ovarian theca cells. Toxicology Letters 272, pages 94-100.
Crossref
Crossref
M.P. Gleeson & D. Montanari. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
64
93
.
Andreas Reichel & Philip Lienau. 2016. New Approaches to Drug Discovery. New Approaches to Drug Discovery
235
260
.
Matthew D. Segall & Edmund J. Champness. 2014. Predictive ADMET. Predictive ADMET
145
166
.
Alex Sparreboom & Walter J. Loos. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
209
227
.
Chi K. Leung, Ying Wang, Siobhan Malany, Andrew Deonarine, Kevin Nguyen, Stefan Vasile & Keith P. Choe. (2013) An Ultra High-Throughput, Whole-Animal Screen for Small Molecule Modulators of a Specific Genetic Pathway in Caenorhabditis elegans. PLoS ONE 8:4, pages e62166.
Crossref
Crossref
Leila Choucha Snouber, Sébastien Jacques, Matthieu Monge, Cécile Legallais & Eric Leclerc. (2012) Transcriptomic analysis of the effect of ifosfamide on MDCK cells cultivated in microfluidic biochips. Genomics 100:1, pages 27-34.
Crossref
Crossref
Iain Beattie, Aaron Smith, Daniel J. Weston, Peter White, Simon Szwandt & Laura Sealey. (2012) Evaluation of laser diode thermal desorption (LDTD) coupled with tandem mass spectrometry (MS/MS) for support of in vitro drug discovery assays: Increasing scope, robustness and throughput of the LDTD technique for use with chemically diverse compound libraries. Journal of Pharmaceutical and Biomedical Analysis 59, pages 18-28.
Crossref
Crossref
Alleyn T. Plowright, Craig Johnstone, Jan Kihlberg, Jonas Pettersson, Graeme Robb & Richard A. Thompson. (2012) Hypothesis driven drug design: improving quality and effectiveness of the design-make-test-analyse cycle. Drug Discovery Today 17:1-2, pages 56-62.
Crossref
Crossref
Stuart W. Paine, Patrick Barton, James Bird, Rebecca Denton, Karelle Menochet, Aaron Smith, Nicholas P. Tomkinson & Kamaldeep K. Chohan. (2010) A rapid computational filter for predicting the rate of human renal clearance. Journal of Molecular Graphics and Modelling 29:4, pages 529-537.
Crossref
Crossref
Rajendra Pratap Singh, Ram Chandra Gupta & Shio Kumar Singh. (2010) Interspecies comparison of the pharmacokinetics and oral bioavailability of 99-357, a potent synthetic trioxane antimalarial compound. European Journal of Pharmaceutical Sciences 41:2, pages 312-319.
Crossref
Crossref
Amin A. Nomeir. 2010. Early Drug Development. Early Drug Development
25
88
.
Mark P. Grillo. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
42
.
Urban Fagerholm. (2007) Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance. Journal of Pharmacy and Pharmacology 59:6, pages 803-828.
Crossref
Crossref
Xiangming Guan. 2009. Evaluation of Drug Candidates for Preclinical Development. Evaluation of Drug Candidates for Preclinical Development
109
133
.
Tomoko Watanabe, Kazuya Maeda, Tsunenori Kondo, Hideki Nakayama, Shigeru Horita, Hiroyuki Kusuhara & Yuichi Sugiyama. (2009) Prediction of the Hepatic and Renal Clearance of Transporter Substrates in Rats Using in Vitro Uptake Experiments. Drug Metabolism and Disposition 37:7, pages 1471-1479.
Crossref
Crossref
Ruchi R. Mittal, Ross A. McKinnon & Michael J. Sorich. (2009) The Effect of Molecular Fields, Lattice Spacing and Analysis Options on CoMFA Predictive Ability. QSAR & Combinatorial Science 28:6-7, pages 637-644.
Crossref
Crossref
Ruchi R. Mittal, Lisa Harris, Ross A. McKinnon & Michael J. Sorich. (2009) Partial Charge Calculation Method Affects CoMFA QSAR Prediction Accuracy. Journal of Chemical Information and Modeling 49:3, pages 704-709.
Crossref
Crossref
Mark P. Grillo. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
655
696
.
Dimitri Semizarov & Eric Blomme. 2008. Genomics in Drug Discovery and Development. Genomics in Drug Discovery and Development
219
291
.
Joel W. Proksch & Keith W. Ward. (2008) Cassette Dosing Pharmacokinetic Studies for Evaluation of Ophthalmic Drugs for Posterior Ocular Diseases. Journal of Pharmaceutical Sciences 97:8, pages 3411-3421.
Crossref
Crossref
Azusa Takahashi, Eriko Komiya, Hideki Kakutani, Takeshi Yoshida, Makiko Fujii, Yasuhiko Horiguchi, Hiroyuki Mizuguchi, Yasuo Tsutsumi, Shin-ichi Tsunoda, Naoya Koizumi, Katsuhiro Isoda, Kiyohito Yagi, Yoshiteru Watanabe & Masuo Kondoh. (2008) Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis. Biochemical Pharmacology 75:8, pages 1639-1648.
Crossref
Crossref
Anna M. Demetriou, David J. Crouch, Helen D. Batey, Stephen Faulkner, Stephen G. Yeates & Francis R. Livens. (2008) Using high-throughput techniques to identify complexants for 137Cs, 60Co and 90Sr. Journal of Materials Chemistry 18:44, pages 5350.
Crossref
Crossref
Christina Lohmann, Birgitta Gelius, Jeanette Danielsson, Ulrica Skoging-Nyberg, Evelyn Hollnack, Adam Dudley, Johanna Wahlberg, Janet Hoogstraate & Lena Gustavsson. (2007) Scintillation proximity assay for measuring uptake by the human drug transporters hOCT1, hOAT3, and hOATP1B1. Analytical Biochemistry 366:2, pages 117-125.
Crossref
Crossref
Walter A. Korfmacher. 2007. Mass Spectrometry in Medicinal Chemistry. Mass Spectrometry in Medicinal Chemistry
399
428
.
K.-C. ChengWalter A. KorfmacherRonald E. WhiteF. George Njoroge. (2007) Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034. Perspectives in Medicinal Chemistry 1, pages 1177391X0700100.
Crossref
Crossref
Bernard Testa & Stefanie D. Krämer. (2006) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 3:10, pages 1053-1101.
Crossref
Crossref
Sarfaraz Niazi. 2006. Handbook of Preformulation. Handbook of Preformulation
1
32
.
Paul R. Ortiz de Montellano. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Hong Mei, Walter Korfmacher & Richard Morrison. (2006) Rapid in vivo oral screening in rats: Reliability, acceptance criteria, and filtering efficiency. The AAPS Journal 8:3, pages E493-E500.
Crossref
Crossref
Namir J. Hassan, David J. Pountney, Catherine Ellis & Danuta E. Mossakowska. (2006) BacMam recombinant baculovirus in transporter expression: A study of BCRP and OATP1B1. Protein Expression and Purification 47:2, pages 591-598.
Crossref
Crossref
Philipp Janser, Ulf Neumann, Wolfgang Miltz, Roland Feifel & Thomas Buhl. (2006) A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors. Bioorganic & Medicinal Chemistry Letters 16:10, pages 2632-2636.
Crossref
Crossref
Paolo Vicini. 2006. Encyclopedia of Medical Devices and Instrumentation. Encyclopedia of Medical Devices and Instrumentation.
T.P. Caremans, C.E.A. Kirschhock, P. Verlooy, J.S. Paul, P.A. Jacobs & J.A. Martens. (2006) Prototype high-throughput system for hydrothermal synthesis and X-ray diffraction of microporous and mesoporous materials. Microporous and Mesoporous Materials 90:1-3, pages 62-68.
Crossref
Crossref
Masuo Kondoh, Azusa Takahashi, Makiko Fujii, Kiyohito Yagi & Yoshiteru Watanabe. (2006) A Novel Strategy for a Drug Delivery System Using a Claudin Modulator. Biological and Pharmaceutical Bulletin 29:9, pages 1783-1789.
Crossref
Crossref
Thomas E. HammJr.Jr., Angela King-Herbert & Mary Ann Vasbinder. 2006. The Laboratory Rat. The Laboratory Rat
803
816
.
Hiroshi Komura, Atsushi Kawase & Masahiro Iwaki. (2005) Application of substrate depletion assay for early prediction of nonlinear pharmacokinetics in drug discovery: Assessment of nonlinearity of metoprolol, timolol, and propranolol. Journal of Pharmaceutical Sciences 94:12, pages 2656-2666.
Crossref
Crossref
Walter A. Korfmacher. (2005) Foundation review: Principles and applications of LC-MS in new drug discovery. Drug Discovery Today 10:20, pages 1357-1367.
Crossref
Crossref
Xiaoying Xu, Hong Mei, Shiyong Wang, Qiao Zhou, Ganfeng Wang, Lisa Broske, Adrienne Pena & Walter A. Korfmacher. (2005) A study of common discovery dosing formulation components and their potential for causing time‐dependent matrix effects in high‐performance liquid chromatography tandem mass spectrometry assays. Rapid Communications in Mass Spectrometry 19:18, pages 2643-2650.
Crossref
Crossref
Hiroshi Komura & Masahiro Iwaki. (2005) NONLINEAR PHARMACOKINETICS OF PROPAFENONE IN RATS AND HUMANS: APPLICATION OF A SUBSTRATE DEPLETION ASSAY USING HEPATOCYTES FOR ASSESSMENT OF NONLINEARITY. Drug Metabolism and Disposition 33:6, pages 726-732.
Crossref
Crossref
Sveinn Briem, Birgitta Pettersson & Erika Skoglund. (2005) Description and Validation of a Four-Channel Staggered LC−MS/MS System for High-Throughput in Vitro Screens. Analytical Chemistry 77:6, pages 1905-1910.
Crossref
Crossref
Hiroshi KOMURAYukie SHIGEMOTOIichiro KAWAHARAKenichi MATSUDARieko ANOYoko MURAYAMAToshiya MORIWAKINagahiro H. YOSHIDA. (2005) High Throughput Screening of Pharmacokinetics and Metabolism in Drug Discovery (III) —Investigation on <i>In silico</i> Model for Membrane Permeability and CYP1A2 Inhibition—創薬における探索薬物動態スクリーニング（III) —膜透過性及びCYP1A2の阻害活性に対する<i>in silico</i>モデルの検討—. YAKUGAKU ZASSHI 125:1, pages 141-147.
Crossref
Crossref
Walter A. Korfmacher. 2005. Identification and Quantification of Drugs, Metabolites and Metabolizing Enzymes by LC-MS. Identification and Quantification of Drugs, Metabolites and Metabolizing Enzymes by LC-MS
7
34
.
A LINDQVIST, S HILKE & E SKOGLUND. (2004) Generic three-column parallel LC–MS/MS system for high-throughput in vitro screens. Journal of Chromatography A 1058:1-2, pages 121-126.
Crossref
Crossref
S.K. Singh, Rajendra Pratap Singh & R.C. Gupta. (2004) HPLC-UV method for assaying 99/357, a synthetic trioxane antimalarial derivative in rat and rabbit serum. Journal of Pharmaceutical and Biomedical Analysis 36:2, pages 371-376.
Crossref
Crossref
Prasarn Manitpisitkul & Ronald E. White. (2004) Whatever happened to cassette-dosing pharmacokinetics?. Drug Discovery Today 9:15, pages 652-658.
Crossref
Crossref
Tarja Toimela, Hanna Mäenpää, Marika Mannerström & Hanna Tähti. (2004) Development of an in vitro blood–brain barrier model—cytotoxicity of mercury and aluminum. Toxicology and Applied Pharmacology 195:1, pages 73-82.
Crossref
Crossref
John H. Ansede & Dhiren R. Thakker. (2004) High‐throughput screening for stability and inhibitory activity of compounds toward cytochrome P450‐mediated metabolism. Journal of Pharmaceutical Sciences 93:2, pages 239-255.
Crossref
Crossref
Kwame N Atuah, Dyfrig Hughes & Munir Pirmohamed. (2004) Clinical Pharmacology. Drug Safety 27:8, pages 535-554.
Crossref
Crossref
Greetje Elaut, Gabriëlla TörökPeggy Papeleu, Tamara Vanhaecke, Georges Laus, Dirk Tourwé & Vera Rogiers. (2019)
Rat Hepatocyte Suspensions as a Suitable
In Vitro
Model for Studying the Biotransformation of Histone Deacetylase Inhibitors
. Alternatives to Laboratory Animals 32:1_suppl, pages 105-112.
Crossref
Crossref
Alex Sparreboom & Walter J. Loos. 2004. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
169
188
.
PA Smith, MJ Sorich, RA McKinnon & JO Miners. (2003)
In silico
insights: Chemical and structural characteristics associated with uridine diphosphate‐glucuronosyltransferase substrate selectivity
. Clinical and Experimental Pharmacology and Physiology 30:11, pages 836-840.
Crossref
Crossref
M. Rajanikanth, K. P. Madhusudanan & R. C. Gupta. (2003)
Simultaneous quantitative analysis of three drugs by high‐performance liquid chromatography/electrospray ionization mass spectrometry and its application to cassette
in vitro
metabolic stability studies
. Rapid Communications in Mass Spectrometry 17:18, pages 2063-2070.
Crossref
Crossref
Naomi Mizuno, Takuro Niwa, Yoshihisa Yotsumoto & Yuichi Sugiyama. (2003) Impact of Drug Transporter Studies on Drug Discovery and Development. Pharmacological Reviews 55:3, pages 425-461.
Crossref
Crossref
J. Fred Pritchard, Malle Jurima-Romet, Mark L. J. Reimer, Elisabeth Mortimer, Brenda Rolfe & Mitchell N. Cayen. (2003) Making Better Drugs: Decision Gates in Non-Clinical Drug Development. Nature Reviews Drug Discovery 2:7, pages 542-553.
Crossref
Crossref
Ute Gerhard, Steven Thomas & Russell Mortishire-Smith. (2003) Accelerated metabolite identification by “Extraction-NMR”. Journal of Pharmaceutical and Biomedical Analysis 32:3, pages 531-538.
Crossref
Crossref
Gary W. Caldwell, Zhengyin Yan, John A. Masucci, William Hageman, Gregory Leo & David M. Ritchie. (2012) Applied Pharmacokinetics in Drug Development. Pharmaceutical Development and Regulation 1:2, pages 117-132.
Crossref
Crossref
Paul A. Smith, Michael J. Sorich, Ross A. McKinnon & John O. Miners. (2003) Pharmacophore and Quantitative Structure−Activity Relationship Modeling: Complementary Approaches for the Rationalization and Prediction of UDP-Glucuronosyltransferase 1A4 Substrate Selectivity. Journal of Medicinal Chemistry 46:9, pages 1617-1626.
Crossref
Crossref
Wilson Z. Shou & Weng Naidong. (2003) Post‐column infusion study of the ‘dosing vehicle effect’ in the liquid chromatography/tandem mass spectrometric analysis of discovery pharmacokinetic samples. Rapid Communications in Mass Spectrometry 17:6, pages 589-597.
Crossref
Crossref
Yung-Chi Lee, Philip D Zocharski & Brian Samas. (2003) An intravenous formulation decision tree for discovery compound formulation development. International Journal of Pharmaceutics 253:1-2, pages 111-119.
Crossref
Crossref
. 2003. High Throughput Bioanalytical Sample Preparation - Methods and Automation Strategies. High Throughput Bioanalytical Sample Preparation - Methods and Automation Strategies
1
40
.
William M. Rockey & Adrian H. Elcock. (2002) Progress toward virtual screening for drug side effects. Proteins: Structure, Function, and Bioinformatics 48:4, pages 664-671.
Crossref
Crossref
Jun Xu & Arnold Hagler. (2002) Chemoinformatics and Drug Discovery. Molecules 7:8, pages 566-600.
Crossref
Crossref
Joy A. Cavagnaro. (2002) Preclinical safety evaluation of biotechnology-derived pharmaceuticals. Nature Reviews Drug Discovery 1:6, pages 469-475.
Crossref
Crossref
György M. Keserűu & László Molnár. (2002) METAPRINT: A Metabolic Fingerprint. Application to Cassette Design for High-Throughput ADME Screening. Journal of Chemical Information and Computer Sciences 42:2, pages 437-444.
Crossref
Crossref
Naomi Mizuno & Yuichi Sugiyama. (2002) Drug Transporters: Their Role and Importance in the Selection and Development of New Drugs. Drug Metabolism and Pharmacokinetics 17:2, pages 93-108.
Crossref
Crossref